Jesse Richman, M.D. is a board-certified ophthalmologist, specializing in the medical and surgical treatment of glaucoma and cataracts. Dr. Richman has received numerous local, state, and national selections as “Top Doc”.

Dr. Richman obtained his undergraduate education at Penn State University, graduating cum laude. Dr. Richman then enrolled at Jefferson Medical College, where he earned his M.D. degree. He performed his internship at Frankford Torresdale Hospital. Dr. Richman completed a three-year residency in Ophthalmology at Brown University, where he was awarded the William Tsiaras Research Award and was appointed Chief Resident of Ophthalmology. He then completed a Glaucoma Fellowship at the world-renowned Wills Eye Hospital, where he continues to provide lectures and teach residents.

Dr. Richman has published many articles in peer-reviewed journals and authored chapters in ophthalmic textbooks. He has presented his top-notch research at several major Ophthalmic assemblies including the American Glaucoma Society, the World Glaucoma Conference, the American Academy of Ophthalmology, the American Society of Ophthalmic Plastic & Reconstructive Surgery, and the Association for Research in Vision and Ophthalmology.

In addition, Dr. Richman has patented a novel diagnostic test for the detection and management of glaucoma, named the Spaeth-Richman Contrast Sensitivity Test. He has developed and taught surgical techniques for multiple eye surgeries. Dr. Richman was the first ophthalmologist to implant the iStent trabecular micro bypass in Delaware. He has also designed a single-step toric marker to aid in the reduction of astigmatism at the time of cataract surgery. Dr. Richman is a member of the American Academy of Ophthalmology and American Glaucoma Society.

Dr. Richman provides treatment at our Cherry Hill, NJ surgical centers.